Cocrystal Pharma, Inc. (COCP)

Kronos Bio Statistics

Total Valuation

COCP has a market cap or net worth of $18.82 million. The enterprise value is $13.63 million.

Market Cap	18.82M
Enterprise Value	13.63M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

COCP has 10.17 million shares outstanding. The number of shares has increased by 0.15% in one year.

Current Share Class	10.17M
Shares Outstanding	10.17M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	35.57%
Owned by Institutions (%)	7.36%
Float	6.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.24.

Current Ratio	4.57
Quick Ratio	4.33
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -106.05% and return on invested capital (ROIC) is -60.03%.

Return on Equity (ROE)	-106.05%
Return on Assets (ROA)	-53.96%
Return on Invested Capital (ROIC)	-60.03%
Return on Capital Employed (ROCE)	-184.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.44M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.14% in the last 52 weeks. The beta is 2.07, so COCP's price volatility has been higher than the market average.

Beta (5Y)	2.07
52-Week Price Change	-3.14%
50-Day Moving Average	1.59
200-Day Moving Average	1.77
Relative Strength Index (RSI)	65.35
Average Volume (20 Days)	137,075

Short Selling Information

The latest short interest is 2,080, so 0.02% of the outstanding shares have been sold short.

Short Interest	2,080
Short Previous Month	4,470
Short % of Shares Out	0.02%
Short % of Float	0.03%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	-10.95M
Operating Income	-16.06M
Pretax Income	-16.75M
Net Income	-15.85M
EBITDA	-15.95M
EBIT	-16.06M
Earnings Per Share (EPS)	-$1.56

Balance Sheet

The company has $6.92 million in cash and $1.73 million in debt, giving a net cash position of $5.19 million or $0.51 per share.

Cash & Cash Equivalents	6.92M
Total Debt	1.73M
Net Cash	5.19M
Net Cash Per Share	$0.51
Equity (Book Value)	7.30M
Book Value Per Share	0.72
Working Capital	6.90M

Cash Flow

Operating Cash Flow	-14.92M
Capital Expenditures	n/a
Free Cash Flow	-14.92M
FCF Per Share	-$1.47

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

COCP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.15%
Shareholder Yield	-0.15%
Earnings Yield	-84.21%
FCF Yield	-79.28%

Analyst Forecast

The average price target for COCP is $6.00, which is 224.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	224.32%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.

Last Split Date	Oct 11, 2022
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1